ORANGE GROVE BIO
Orange Grove Bio (“OGB”) is a preclinical drug investment and development platform focused on driving down the cost of drug discovery and advancing therapies into clinical trials.
ORANGE GROVE BIO
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business GStatic Google Static Content Sectigo SSL Sectigo Domain SSL Wix
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-10-05 | IpiNovyx Bio | Orange Grove Bio investment in Seed Round - IpiNovyx Bio | 10 M USD |
More informations about "Orange Grove Bio"
Orange Grove Bio | A Research-Based Biotechnology …
Orange Grove Bio Sets Sights on Rapidly Emerging Middle East Biotech Ecosystem through New Academic Collaboration with Weizmann Institute of Science Partnership represents firm’s second international collaboration and …See details»
Meet Our People – Orange Grove Bio
As CEO of Orange Grove Bio, Ryan is dedicated to advancing transformative therapies for cancer, autoimmune, and inflammatory diseases. Leading a team of venture partners with …See details»
Our Mission – Orange Grove Bio
Orange Grove Bio is committed to accelerating the development of innovative, patient-centric therapies for cancer, autoimmune, and inflammatory diseases. We believe in cultivating a collaborative ecosystem that connects early-stage …See details»
Orange Grove Bio - Crunchbase Investor Profile & Investments
Orange Grove Bio entered into a new academic collaboration with the Weizmann Institute of Science to engage with the Middle East biotech ecosystem. Additionally, Orange Grove Bio …See details»
Orange Grove Bio - LinkedIn
Orange Grove Bio was established with a clear vision: to bridge the gap between promising research programs and the successful development and commercialization of transformative therapies.See details»
Orange Grove Bio - VentureRadar
Orange Grove Bio (OGB) is a capital allocation and asset development biotech company. OGB partners with universities, academic medical centers, and entrepreneurs to develop innovative …See details»
Orange Grove Bio investment portfolio - PitchBook
Dec 23, 2020 Orange Grove Bio's latest investment was on 01-Jan-2025 in Allonix Therapeutics, a company within the Drug Discovery industry. Data Transparency. Meet our data hygiene team. Discover how our experts ensure …See details»
Orange Grove Bio - Funding, Financials, Valuation & Investors
Orange Grove Bio is funded by 2 investors. Small Business Innovation Research and THE CATALYTIC IMPACT FOUNDATION (CIF) are the most recent investors. Unlock for freeSee details»
Purchase access to Orange Grove Bio | Yale Case Study Research …
In late 2023, Orange Grove Bio co-founder and CEO Marc Appel considered the future of his private drug development investment firm. Orange Grove Bio, (OGB) had finished its fourth- …See details»
Orange Grove Bio - Contacts, Employees, Board Members
Orange Grove Bio has 2 current employee profiles, including Chief Executive Officer Marc Appel. Marc Appel Chief Executive Officer Ryan Fox Chief Business Operations OfficerSee details»
Portfolio - Orange Grove Bio
Privacy Policy; Terms & Conditions; FCOI POLICY © 2023 Orange Grove Bio LLC, All Rights ReservedSee details»
Orange Grove Bio Subsidiary Awarded $2.05 Million SBIR Phase II …
Sep 28, 2023 OGB Also Announces Key Appointments to Board of Senior Advisors and the Opening of New HeadquartersCINCINNATI, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Orange …See details»
Orange Grove Bio Expands Academic Collaboration Activities
Mar 23, 2023 Contacts: Orange Grove Bio Taylor Negrete (513) 448-2499 Vida Strategic Partners (on behalf of Orange Grove Bio) Tim Brons (Media) (415) 674-7402 Contact closeSee details»
Orange Grove Bio Provides Corporate Update Highlighting Key …
Jun 23, 2022 John C. Byrd, M.D., Renowned Cancer Clinician and Researcher, Named Chair of Scientific Advisory Board New Collaboration with Northeast Ohio Medical University Further …See details»
The University of Pittsburgh and Orange Grove Bio Establish …
Nov 17, 2021 Orange Grove Bio, a USA-based pre-clinical drug investment and development firm, and SV Investment, a South Korea-based venture capital and private equity firm, today …See details»
Polsky Center Teams with Orange Grove Bio to Catalyze Biotech ...
Jul 23, 2024 The University of Chicago’s Polsky Center for Entrepreneurship and Innovation has signed a strategic agreement with Orange Grove Bio (OGB), an integrated biopharmaceutical …See details»
Orange Grove Bio Selects Cincinnati Innovation District® for …
CINCINNATI, Nov. 3, 2021 /PRNewswire/ -- Orange Grove Bio, a New York-based preclinical drug investment and development firm, and the University of Cincinnati (UC), a Carnegie Level …See details»
Orange Grove Bio: Filling the Gap in Preclinical Drug Development
Jan 25, 2020 Orange Grove Bio is designed to fulfill today’s unmet needs by focusing on the right opportunities for the next five years, working with the best possible university partners, …See details»
Orange Grove Bio — Catalytic Impact Foundation
Orange Grove Bio (“OGB”) is a preclinical drug investment and development platform focused on driving down the cost of drug discovery and advancing therapies into clinical trials. They are …See details»
Orange Grove Bio Expands Academic Collaboration Activities ...
Mar 23, 2023 Orange Grove Bio will work collaboratively with each group to identify and support opportunities for company creation and drug development in the areas of oncology, as well as …See details»